亚太区股市全面随美股回落 港股跌幅扩至200点
美股昨晚全面低收续吐0.8%-1.2%,美国10月建筑许可环比意外零增长,但新屋动工续升4.9%胜预期,加上药厂辉瑞指新冠疫苗研发最终试验结果成功率达95%,支持三大指数早段造好,但纽约市因应疫情严峻再度关闭学校,市场担心疫情恶化重新封城,大市掉头向,30只蓝筹有27只下跌,美国批准波音737 MAX客机复飞,刺激该股早段进一步升至223.02美元逾五个月高遇阻倒跌3.2%结束三连涨,可口可乐、安进、Honeywell、联合健康、前天已急吐9%的Walgreens及雪佛龙依次跌2%-3.2%,拖累道指由早段曾弹147点至29,930,转为续跌344点或近1.2%收29,438,标普也倒跌近1.2%;但获纳入标指Tesla获大摩上调目标价,股价续涨10%曾逼近500美元,纳指仅反覆续吐0.8%。此外,欧央行行长德拉吉指,不会因为疫苗有好消息而收紧宽松政策,较早收市的欧洲主要股市全面反覆升0.3%-0.9%,富时最弱。
道指及标普期货反覆回稳,但纳指期货反覆续跌0.1%报11,884。亚太区股市早段普遍偏软。美元兑日圆於亚洲回稳定报103.81,日经继昨天由逾29年高位回吐逾1%後,今早低见25,532,现造25,618,续吐0.4%。
台湾加权指数扭转昨天高收续升1.3%屡创纪录高强势,今早回吐0.2%报13,747。韩股回落0.2%报2,541。澳洲10月季调後失业率续微升至7%胜预期,澳洲200仅由近9个月高位回落0.1%报6,523。新西兰股市继昨天由纪录高位回吐逾1%结束连日升势後,今早续吐0.3%报12,569。星股扭三连涨,由逾五个月高位回吐0.5%报2,773。马股续跌0.9%报1,590。
港股继昨天反覆续升0.5%曾见26,618逾四个月高後,今早低开83点或0.3%报26,460,在中资金融和科技股及友邦(012399.HK)主导,跌幅扩至211点或0.8%,报26,333。
沪指继昨天反覆回升0.3%後,今早低开近0.3%报3,339,现造3,335,跌近0.4%;深成继昨天反覆续吐0.5%後,今早低开近0.2%报13,633,跌幅扩至0.5%报13,585。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.